26.4 ICU Liberation, Analgosedation, Goals of Care & Critical Care Ethics

The ABCDEF ICU Liberation Bundle

The ABCDEF Bundle is an evidence-based, multicomponent organizational framework developed to optimize recovery, liberate patients from mechanical ventilation, prevent delirium, and mitigate Post-Intensive Care Syndrome (PICS). In the ICU Liberation Collaborative (more than 15,000 adults, observational), higher bundle compliance was associated in a dose-dependent manner with lower in-hospital mortality, fewer days on mechanical ventilation, less coma and delirium, and fewer ICU readmissions.

Bundle Components and Implementation

• A: Assess, Prevent, and Manage Pain: Systematically monitor pain using validated behavioral scales. Pain is the leading trigger of ICU agitation; adequate analgesia must precede any sedative escalation.
• B: Both Spontaneous Awakening Trials (SAT) and Spontaneous Breathing Trials (SBT): Paired daily "Wake Up and Breathe" protocol. Coordinate an early morning SAT (holding all continuous sedatives and opioids used for sedation) with an SBT (low pressure support $0 - 5\text{ cmH}_2\text{O}$ or T-piece for 30 to 120 minutes) once the patient awakens.
  • SAT Safety Screen: No active seizures, no ongoing alcohol withdrawal, no escalating sedative doses, no active neuromuscular blockade, and no intracranial hypertension.
  • SAT Failure Criteria: Sustained agitation (RASS $> +2$), tachypnea (respiratory rate $> 35\text{ breaths/min}$ for $> 5\text{ minutes}$), oxygen desaturation ($< 88\%$), acute cardiac arrhythmias, or hemodynamic instability.
  • SBT Safety Screen: Passed SAT or alert, no excessive vasopressor requirements, $\text{PaO}_2/\text{FiO}_2 \ge 150 - 200\text{ mmHg}$ on $\text{PEEP} \le 8\text{ cmH}_2\text{O}$ and $\text{FiO}_2 \le 0.40 - 0.50$, and adequate spontaneous inspiratory efforts.
  • SBT Success Parameter: Rapid Shallow Breathing Index ($\text{RSBI} = f/V_T < 105\text{ breaths/min/L}$) without diaphoresis, respiratory distress, or hemodynamic instability.
• C: Choice of Analgesia and Sedation: Target light sedation (Richmond Agitation-Sedation Scale [RASS] score $-1$ to $0$). Avoid continuous benzodiazepine infusions; utilize non-benzodiazepine sedatives (propofol or dexmedetomidine).
• D: Delirium Assessment, Prevention, and Management: Screen every shift using the Confusion Assessment Method for the ICU (CAM-ICU) or the Intensive Care Delirium Screening Checklist (ICDSC). Non-pharmacological prevention is the foundation: sleep hygiene protocols (minimizing nighttime vitals and alarms), daytime natural lighting, early reorientation, sensory aids (hearing aids and glasses), and eliminating unnecessary physical restraints.
• E: Early Mobility and Exercise: Multidisciplinary physical and occupational therapy initiated within 48 hours of mechanical ventilation. Structured progressive mobilization advances from passive range of motion in bed to active sitting, edge-of-bed dangling, standing transfers, and ambulation while intubated.
• F: Family Engagement and Empowerment: Unrestricted, liberal family visitation policies, active family participation in multidisciplinary ICU rounds, and structured family education regarding delirium and critical illness recovery.

---

Analgosedation and Sedation Management (SCCM PADIS Guidelines)

The Society of Critical Care Medicine (SCCM) 2018 Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption (PADIS) establish analgosedation (analgesia-first sedation) as the premier management paradigm. In an analgosedation-first protocol, clinicians assess and treat pain and discomfort with intravenous opioids before administering or escalating sedative agents.

The 2025 PADIS focused update suggests dexmedetomidine over propofol for mechanically ventilated adults when light sedation is the goal, suggests enhanced (early) mobilization and melatonin to improve sleep, and makes no recommendation for or against antipsychotics to treat delirium.

Validated Behavioral Pain Scales in Non-Communicative Patients

1. Critical-Care Pain Observation Tool (CPOT): Evaluates four behavioral domains:
   • Facial expression (relaxed = 0; tense = 1; grimacing = 2)
   • Body movements (absence of movements = 0; protection/slow movements = 1; restlessness/pulling at tubes = 2)
   • Muscle tension via passive arm flexion/extension (relaxed = 0; tense/resisting = 1; very tense/rigid = 2)
   • Ventilator compliance for intubated patients (tolerating vent = 0; coughing/alarms activate but stop spontaneously = 1; fighting ventilator/asynchrony = 2) or Vocalization for extubated patients (normal tone = 0; sighing/moaning = 1; crying out/sobbing = 2).
   • Scoring: Ranges from $0$ to $8$; a score $\ge 3$ indicates clinically significant pain requiring therapeutic analgesia.
2. Behavioral Pain Scale (BPS): Evaluates facial expression (1 to 4), upper limb movements (1 to 4), and compliance with mechanical ventilation (1 to 4). Scores range from $3$ to $12$; a score $> 5$ indicates significant pain.

Sedation Targets and Pharmacological Agents

Clinical guidelines recommend targeting light sedation (RASS $-1$ [drowsy; sustained eye contact $> 10\text{ s}$ to voice] or RASS $0$ [alert and calm]). Deep sedation (RASS $-3$ to $-5$) is an independent predictor of prolonged mechanical ventilation, increased ICU-acquired weakness, higher delirium incidence, and elevated 2-year mortality. Deep sedation is strictly restricted to patients with severe ARDS receiving neuromuscular blockade, targeted temperature management post-cardiac arrest, refractory status epilepticus, or severe intracranial hypertension.

---

Post-Intensive Care Syndrome (PICS & PICS-F)

Post-Intensive Care Syndrome encompasses new or worsening multidimensional impairments arising after critical illness and persisting long after hospital discharge:

1. Physical Impairment: ICU-Acquired Weakness (ICUAW), comprising Critical Illness Polyneuropathy (CIP; axonal motor and sensory neuropathy) and Critical Illness Myopathy (CIM; primary non-necrotizing myopathy with loss of myosin thick filaments). Features include diffuse, symmetric flaccid quadriparesis, diaphragmatic atrophy, and severe muscle wasting.
2. Cognitive Impairment: Impairments in memory, executive function, attention, and processing speed, affecting $50\%$ to $70\%$ of ICU survivors at discharge and persisting for years, clinically mirroring moderate traumatic brain injury.
3. Psychological Impairment: High prevalence of Post-Traumatic Stress Disorder (PTSD, $20\% - 30\%$), major depression ($30\%$), and generalized anxiety ($30\% - 40\%$).
4. PICS-Family (PICS-F): Chronic psychological distress occurring in family caregivers, including anxiety, depression, complicated grief, and PTSD.

---

Palliative Care, Goals of Care & Critical Care Bioethics

Structured Family Conferences: The VALUE Mnemonic

High-quality, proactive communication within 24 to 48 hours of ICU admission reduces family psychological trauma. The evidence-based VALUE Communication Strategy guides these conferences:

• V: Value family statements: Explicitly validate their insights regarding the patient's identity and personal values.
• A: Acknowledge family emotions: Name and normalize emotional reactions (grief, guilt, fear, despair).
• L: Listen to the family: Ensure the family speaks more than $50\%$ of the conference time; ask open-ended questions.
• U: Understand the patient as a person: Inquire about the patient's hobbies, daily functional values, religious convictions, and what constitutes an acceptable quality of life.
• E: Elicit family questions: Receptively invite inquiries and verify mutual understanding.

The Shared Decision-Making Framework

Clinicians and families participate in Shared Decision-Making: clinicians provide medical reality, prognostic trajectories, and technical feasibility, while family surrogates articulate the patient's authenticated values, goals, and religious/philosophical beliefs. Clinicians must synthesize this information to make clear, goal-concordant recommendations rather than abandoning families to make complex medical decisions in isolation.

Surrogate Decision-Making Standards and Legal Hierarchy

When a patient lacks decision-making capacity, surrogate decision-makers must adhere to an explicit ethical hierarchy:

1. Substituted Judgment Standard: The surrogate must decide based on what the patient would have decided if they were able to speak for themselves, honoring their known values, prior statements, and lived philosophy.
2. Best Interests Standard: Utilized only when the patient's prior preferences and values are completely unknown or impossible to ascertain. The surrogate decides based on what a reasonable person would choose, balancing objective burdens and clinical benefits.

Legal Surrogate Hierarchy (typical statutory priority when no healthcare proxy or durable power of attorney exists; the order varies by state): Legal spouse / domestic partner $\to$ Adult children $\to$ Parents $\to$ Adult siblings $\to$ Nearest adult relative or close personal friend.

Ethical Principles and Life-Sustaining Treatment

Compassionate Terminal Extubation Protocol

When goals transition strictly to comfort, a planned terminal extubation must be executed systematically:

1. Pre-Emptive Symptom Control: Anticipate and abolish air hunger, dyspnea, and pain before changing ventilator settings. Administer scheduled intravenous opioids (e.g., morphine $5 - 10\text{ mg}$ or fentanyl $50 - 100\text{ mcg}$) and benzodiazepines (midazolam $1 - 2\text{ mg}$) titrated to comfort.
2. Neuromuscular Blockade Confirmation: Verify complete recovery from neuromuscular blockade (Train-of-Four 4/4) prior to withdrawing life support to ensure the patient does not experience conscious paralysis or suffocating distress.
3. Discontinuation of Non-Comfort Measures: Turn off physiological monitors, silence all alarms, and discontinue all non-comfort medications (vasopressors, antibiotics, blood transfusions, artificial nutrition, insulin).
4. Airway Extubation and Secretion Management: Suction the oropharynx, deflate the endotracheal tube cuff, gently remove the tube, and place low-flow nasal cannula or leave on room air. Administer anticholinergics (glycopyrrolate $0.2 - 0.4\text{ mg}$ IV/SC or scopolamine patch) to eliminate noisy upper airway secretions ("death rattle").
5. The Principle of Double Effect: Administering high doses of opioids and sedatives with the primary therapeutic intent of relieving pain and air hunger is ethically and legally sound, even if it foreseeably hastens death, provided the dosage is titrated strictly to symptom control.

---

Organ Donation Framework: DBD vs. DCD

CMS Conditions of Participation require hospitals to notify the regional Organ Procurement Organization (OPO) in a timely manner about imminent and actual deaths, using OPO-defined clinical triggers (commonly GCS $\le 5$, loss of brainstem reflexes, or before a planned withdrawal of life support). Donation requests are made by OPO staff or a trained designated requester, kept separate ("decoupled") from the conversation about the patient's prognosis and goals of care. The treating team focuses on the patient's care and the family's support and does not raise donation before the OPO is involved.

Legal Death Determination (UDDA)

The Uniform Determination of Death Act establishes that an individual is legally dead if they have sustained either:

1. Irreversible cessation of circulatory and respiratory functions, or
2. Irreversible cessation of all functions of the entire brain, including the brainstem.

Donation Pathways

• Donation after Brain Death (DBD): The patient meets formal neurological criteria for death (deep coma of known irreversible etiology, complete absence of all brainstem reflexes, and a positive apnea test demonstrating absence of respiratory effort with $\text{PaCO}_2 \ge 60\text{ mmHg}$ and $\ge 20\text{ mmHg}$ above baseline and arterial $\text{pH} < 7.30$, per the 2023 AAN/AAP/CNS/SCCM guideline). Somatic organ perfusion is maintained mechanically until surgical procurement in the operating room.
• Donation after Circulatory Death (DCD): Applies to patients who have devastating, non-survivable neurological or medical illness but do not meet brain death criteria, whose surrogates have independently made the decision to withdraw life-sustaining treatment. Life-sustaining therapies are withdrawn in the operating room or ICU. Following the irreversible cessation of circulation and pulse, an obligatory observation period ($2$ to $5\text{ minutes}$) transpires before death is declared, after which rapid organ procurement commences. If the patient does not arrest within a predefined window (typically 60 to 120 minutes), organ donation is cancelled, and the patient transitions to inpatient comfort care.